| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 888 | 14.679 | 26.238 | 41.466 | 48.559 |
| Total Income - EUR | - | - | - | - | - | 888 | 14.533 | 26.497 | 41.955 | 48.559 |
| Total Expenses - EUR | - | - | - | - | - | 838 | 14.043 | 24.232 | 43.943 | 52.393 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 50 | 490 | 2.265 | -1.988 | -3.834 |
| Net Profit/Loss - EUR | - | - | - | - | - | 24 | 195 | 1.927 | -2.408 | -4.321 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Drx Darexia Grup S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 2.567 | 1.288 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.102 | 3.543 | 11.450 | 11.198 | 10.045 |
| Inventories | - | - | - | - | - | 415 | 1.817 | 8.718 | 2.911 | 3.222 |
| Receivables | - | - | - | - | - | 400 | 1.680 | 2.096 | 1.062 | 5.172 |
| Cash | - | - | - | - | - | 287 | 46 | 636 | 7.225 | 1.650 |
| Shareholders Funds | - | - | - | - | - | 65 | 259 | 2.186 | -228 | -4.548 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.037 | 6.412 | 10.552 | 11.674 | 14.857 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8020 - 8020" | |||||||||
| CAEN Financial Year |
8020
|
|||||||||
Comments - Drx Darexia Grup S.r.l.